In a combined fertility and embryo-fetal development study in rats, subcutaneous doses of 0.01, 0.03 and 0.09 mg/kg/day (0.2-, 0.7- and 2.1-fold the MRHD) were administered to male and female rats
Heres what I recommend patients evaluate: Medical Oversight You should be seen by a licensed medical provider who understands obesity medicine
Practice healthy sleep habits Poor sleep can contribute to daytime fatigue, so if you havent been enjoying at least seven hours of restful sleep on a regular basis, now might be the time to change that if you can
However, significant metabolic changes that occur during treatmentparticularly substantial weight losscould theoretically affect menstrual patterns
The pregnancy weight gain needs to come off, theres often a feeling of I was doing so well before pregnancy, and theres concern about weight regain during the extended time off medication